Effects of the use of semaglutide as a pharmacological option for weight loss in adults with BMI > 25 Kg/m²: a scoping review. RSD [Internet]. 2023 Apr. 1 [cited 2025 Jun. 29];12(4):e9012440955. Available from: https://ojs34.rsdjournal.org/index.php/rsd/article/view/40955